S.E.H. Etaiw et al. / Spectrochimica Acta Part A 79 (2011) 1331–1337
1337
Table 5
References
IC50 (M) dose of the compound which survival to 50%.
[
[
1] S.R. Collinson, D.E. Fenton, Coord. Chem. Rev. 148 (1996) 19–40.
2] A.K. Sharma, S. Chandra, Spectrochim. Acta A 78 (2011) 337–342.
Compounds
Cell lines
HELA
MCF7
HEPG2
HCT116
HEP2
[3] H.F. Abd El-halim, M.M. Omar, G.G. Mohamed, Spectrochim. Acta A 78 (2011)
6–44.
3
IC50 (M)
[4] T.B.S.A. Ravoof, K.A. Crouse, M.I.M. Tahir, F.N.F. How, R. Rosli, D.J. Watkins,
Transit. Met. Chem. 35 (7) (2010) 871–876, and references therein.
L
0.186
0.027
0.049
0.025
–
–
–
–
–
–
–
–
–
–
−ve
[
[
[
5] N.P. Priya, S. Arunachalam, A. Manimaran, D. Muthupriya, C. Jayabalakrishnan,
Spectrochim. Acta A 72 (2009) 670–676.
6] C. Ramalingan, S. Balasubramanian, S. Kabilan, M. Vasudevan, Eur. J. Med. Chem.
39 (2004) 527–533.
7] G.T. Zitouni, S. Demirayak, A. Özdemir, Z.A. Kaplancikli, M.T. Yildiz, Eur. J. Med.
Chem. 39 (2004) 267–272.
[
[
[
CuLCl(H2O)3]Cl
NiL(OAc)2]
ZnL(OAc)2]
0.049
−ve
0.027
0.048
0.0042
E. coli compared with ceftriaxone. The growth inhibiting effect was
quantitatively determined by the (M/C) ratio of the surviving cell
number. The results also show that the inhibitory effect is increased
with an increase in concentration of the compounds, Fig. 3. Bio-
logical and pharmaceutical activates of Schiff base derived from
[8] M.A. Neelakantan, S.S. Marriappan, J. Dharmaraja, T. Jeyakumar, K. Muthuku-
maran, Spectrochim. Acta A 71 (2008) 628–635.
[
9] V.E. Borisenko, A. Koll, E.E. Kolmaov, A.G. Rjasnyi, J. Mol. Struct. 783 (2006)
01–115.
[10] V. Bénéteau, T. Besson, J. Guillard, S. Léonce, B. Pfeiffer, Eur. J. Med. Chem. 34
1999) 1053–1060, and references therein.
1
(
[
[
11] S.E. Castillo-Blum, N. Barba-Behrens, Coord. Chem. Rev. 196 (2000) 3–30.
12] I. Sakyan, E. Logoglu, S. Arslan, N. Sari, N. S¸ akiyan, Bio Metals 17 (2004) 115–
120.
13] O.L. Shotwell, F.H. Stodola, W.R. Michael, L.A. Lindenfelser, R.G. Dworschack,
T.G. Pridham, J. Am. Chem. Soc. 80 (15) (1958) 3912–3915.
2
-thiophene carboxaldehyde and aminobenzoic acid have been
studied in comparison to Cu, Fe, Zn, Ni and Co complexes [18]. These
compounds were screened for the antimicrobial activity against
bacterial species and fungal species. E. coli was inhibited by Fe, Cu
and Zn complexes at concentration 5 mg which formed inhibition
zones ranged between 11 and 15 mm. In addition to complexes had
anticandidal activity against Candida sp. with low inhibition zone
sized 5 mm.
[
[
14] P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. War-
ren, H. Bokesch, S. Kenney, M.R. Boyd, J. Natl. Cancer Inst. 82 (1990) 1107–
1112.
[
[
15] N. Nawar, N.M. Hosny, Transit. Met. Chem. 25 (2000) 1–8.
16] N.B. Colthup, L.H. Daly, S.E. Wiberley, Introduction to Infrared and Raman Spec-
troscopy, 2nd ed., Academic Press, Inc. London Ltd., 1975.
[
17] M. Bo cˇ a, M. Izakovi cˇ , G. Kickelbick, M. Valko, F. Renz, H. Fuess, K. Matuzsná,
Polyhedron 24 (2005) 1913–1921.
18] G.G. Mohamed, M.M. Omar, A.M.M. Hindy, Spectrochim. Acta A 62 (2005)
3.9. Antitumor activity
[
1
140–1150, and references therein.
[19] N.A. Nawar, A.M. Shallaby, N.M. Hosny, M.M. Mostafa, Transit. Met. Chem. 26
2001) 180–185.
20] A.M. Donia, H.A. El-Boraey, M.F. El-Samalehy, J. Therm. Anal. Calc. 73 (2003)
87–1000.
[21] S.E. Etaiw, R.S. Farag, A.M. El-Atrash, A.M.A. Ibrahim, Spectrochim. Acta A 48
1992) 1025–1026.
In vitro potential cytotoxicity of Cu(II), Ni(II) and Zn(II) com-
(
plexes was tested against cervical carcinoma (HELA) and breast
carcinoma (MCF 7). The relation between surviving fraction and
drug concentration is plotted to get the survival curve of each
tumor cell line, Fig. 4, IC50 values are cited in Table 5. The results
of the cytotoxic assays showed that the complexes have signif-
icant bioactivity towards human HELA cell lines than the free
Schiff base L. The Zn(II)-complex showed the best cytotoxic activ-
ity towards this cell line. Cu(II)-complex showed slight cytotoxic
activity towards breast carcinoma (MCF 7) cell line. On the other
hand, Ni(II)-complex does not show any cytotoxic activity towards
human MCF7 cell line. According to the significant cytotoxic activ-
ity of Zn-complex towards (HELA) and (MCF 7) cell lines, in vitro
potential cytotoxicity of Zn (II) complex was tested against liver
carcinoma (HEPG2), colon carcinoma (HCT116) and larynx carci-
noma (HEP2) cell lines. The results show that the Zn-complex has
significant cytotoxic activity towards all cell lines except HEP2 cell
line. In conclusion, the Zn-complex exhibits significant decrease in
surviving fraction of HCT116, MCF7 and HELA human cancer cells
[
9
(
[
[
22] A.M.A. Ibrahim, S.E.H. Etaiw, Polyhedron 16 (10) (1997) 1585–1594.
23] M.S. Ibrahim, A.H. Werida, S.E.H. Etaiw, Transit. Met. Chem. 28 (2003) 585–
591.
[
[
[
[
[
[
24] M.S. Refat, I.M. El-Deen, Z.M. Anwer, S. El-Ghol, J. Mol. Struct. 920 (2009)
149–162.
25] F. Firdaus, K. Fatma, A.U. Khan, M. Shakir, J. Serb. Chem. Soc. 8–9 (2009)
939–951, and references therein.
26] A.D. Kulkarni, S.A. Patil, P.S. Badami, Int. J. Electrochem. Sci. 4 (2009) 717–729,
and references therein.
27] M.S. Masoud, A.A. Soayed, A.E. Ali, O.K. Sharsherh, J. Coord. Chem. 56 (8) (2003)
725–742, and references therein.
28] J.C. Bailar, H.J. Emeléus, R. Nyholm, A.F. TrotmanDickenson, Comprehensive
Inorganic Chemistry, 1st ed., Pergamon Press Ltd., Oxford, 1973, p. 1152.
29] T. Dudev, C. Lim, J. Am. Chem. Soc. 122 (2000) 11146–11153.
[30] V.P. Daniel, B. Murukan, B.S. Kumari, K. Mohanan, Spectrochim. Acta A 70 (2008)
403–410.
[
31] D.M.L. Goodgame, M. Goodgame, F.A. Cotton, Am. Chem. Soc. 83 (1961)
161–4167.
4
[
32] F. Rafat, M.Y. Siddiqi, K.S. Siddiqi, J. Serb. Chem. Soc. 69 (8–9) (2004) 641–
649.
[
[
33] B.J. Hathaway, D.E. Billing, Coord. Chem. Rev. 5 (1970) 143–207.
34] B. Jezowska-Trzebiatowska, J. Lisowski, A. Vogt, P. Chmielewski, Polyhedron 7
Appendix A. Supplementary data
(
1988) 337–343.
[35] R.J. Dudley, B.J. Hathaway, J. Chem. Soc. A (1970) 1725–1728.
[36] Y. Nishida, S. Oshio, S. Kida, Inorg. Chim. Acta 23 (1977) 59–61.
[37] P. Beardwood, J.F. Gibson, J. Chem. Soc. Dalton Trans. (1983) 737–748.
[38] S.A. Cotton, J.F. Gibson, J. Chem. Soc. A (1971) 803–809.
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.saa.2011.04.064.